190 related articles for article (PubMed ID: 33408715)
1. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19.
Leonardi AJ; Proenca RB
Front Immunol; 2020; 11():600405. PubMed ID: 33408715
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Berthelot JM; Lioté F; Maugars Y; Sibilia J
Front Immunol; 2020; 11():607069. PubMed ID: 33335532
[TBL] [Abstract][Full Text] [Related]
3. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
4. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
Bellesi S; Metafuni E; Hohaus S; Maiolo E; Marchionni F; D'Innocenzo S; La Sorda M; Ferraironi M; Ramundo F; Fantoni M; Murri R; Cingolani A; Sica S; Gasbarrini A; Sanguinetti M; Chiusolo P; De Stefano V
Br J Haematol; 2020 Oct; 191(2):207-211. PubMed ID: 32679621
[TBL] [Abstract][Full Text] [Related]
5. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
6. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
Peng X; Ouyang J; Isnard S; Lin J; Fombuena B; Zhu B; Routy JP
Front Immunol; 2020; 11():596631. PubMed ID: 33384690
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
[TBL] [Abstract][Full Text] [Related]
8. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
[TBL] [Abstract][Full Text] [Related]
9. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
[TBL] [Abstract][Full Text] [Related]
10. Fas (CD95)-independent regulation of immune responses by antigen-specific CD4-CD8+ T cells.
Teh SJ; Dutz JP; Motyka B; Teh HS
Int Immunol; 1996 May; 8(5):675-81. PubMed ID: 8671654
[TBL] [Abstract][Full Text] [Related]
11. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
Sevilya Z; Chorin E; Gal-Garber O; Zelinger E; Turner D; Avidor B; Berke G; Hassin D
Front Immunol; 2018; 9():2068. PubMed ID: 30254642
[TBL] [Abstract][Full Text] [Related]
12. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
[TBL] [Abstract][Full Text] [Related]
14. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
Estaquier J; Tanaka M; Suda T; Nagata S; Golstein P; Ameisen JC
Blood; 1996 Jun; 87(12):4959-66. PubMed ID: 8652808
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
17. Activated T lymphocytes disappear from circulation during endotoxemia in humans.
Krabbe KS; Bruunsgaard H; Qvist J; Fonsmark L; Møller K; Hansen CM; Skinhøj P; Pedersen BK
Clin Diagn Lab Immunol; 2002 May; 9(3):731-5. PubMed ID: 11986289
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively.
Zhong J; Gilbertson B; Cheers C
Immunol Cell Biol; 2003 Dec; 81(6):480-6. PubMed ID: 14636245
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
Sloand EM; Kumar PN; Kim S; Chaudhuri A; Weichold FF; Young NS
Blood; 1999 Aug; 94(3):1021-7. PubMed ID: 10419894
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism.
Gorbachev AV; Fairchild RL
J Immunol; 2004 Feb; 172(4):2286-95. PubMed ID: 14764697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
